Nephro Care India Confirms 100% IPO Fund Utilization Without Deviations
Nephro Care India Ltd · Others (Uncategorized) · 12 Nov 2026, 11:27 pm
Nephro Care India Confirms 100% IPO Fund Utilization Without Deviations Nephro Care India Limited submitted its Statement of Deviation or Variation under Regulation 32 for the quarter ended 30th Sep'26, reporting zero deviation in IPO proceeds utilization. As certified by statutory auditor K. K. Chanani & Associates, total proceeds were fully utilized in line with prospectus objects: ₹2,615.34 lacs deployed toward establishing Vivacity Multi Specialty Hospital in Madhyamgram, Kolkata, and ₹1,002.70 lacs allocated for general corporate purposes, leaving no unutilized balance.
Original exchange filing (PDF)
More announcements from Nephro Care India Ltd
- Nephro Care India Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 12 Nov 2026
- Nephro Care India Limited has informed the Exchange about related Party Transactions · 12 Nov 2026
- Nephro Care India Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 12 Nov 2026
- NEPHRO CARE INDIA LIMITED has informed the Exchange about Board Meeting to be held on 12-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 12 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters · 12 Nov 2026
- SDD Certificate for the quarter ended 30th September 2026 · 05 Oct 2026
- Nephro Care India Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the quarter ended 30th September 2026 · 01 Oct 2026
- Nephro Care India Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 25, 2026. Further, the company has informed the Exchange regarding voting results. · 28 Sept 2026
